$CYDY
CytoDyn Inc.

2018 Q4 Form 10-Q Financial Statement

#000119312519005378 Filed on January 09, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q2 2018 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.660M $2.190M $1.970M
YoY Change 65.22% 3.79% 41.73%
% of Gross Profit
Research & Development $12.87M $8.920M $12.08M
YoY Change 41.78% 59.29% 84.81%
% of Gross Profit
Depreciation & Amortization $150.0K $90.00K $90.00K
YoY Change 66.67% 0.0% 0.0%
% of Gross Profit
Operating Expenses $15.69M $11.20M $14.14M
YoY Change 45.59% 43.56% 76.38%
Operating Profit -$15.69M -$14.14M
YoY Change 45.59% 76.38%
Interest Expense $1.727M $393.7K $3.069M
YoY Change 72.2% -59.41% 4137.05%
% of Operating Profit
Other Income/Expense, Net $830.0K $1.967M -$740.4K
YoY Change -32.47% 102.78% 3108.27%
Pretax Income -$17.13M -$9.620M -$17.95M
YoY Change 56.49% 40.85% 121.27%
Income Tax -$2.827M $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.31M -$9.624M -$17.95M
YoY Change 30.67% 40.91% 121.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$55.23K -$45.34K -$100.8K
COMMON SHARES
Basic Shares Outstanding 292.9M shares 218.7M shares 212.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q2 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $770.0K $1.230M $4.950M
YoY Change -40.77% -30.9% -36.54%
Cash & Equivalents $772.4K $1.231M $4.947M
Short-Term Investments
Other Short-Term Assets $3.160M $2.090M $1.670M
YoY Change -8.14% -51.95% -66.19%
Inventory
Prepaid Expenses $200.9K $227.2K $265.7K
Receivables
Other Receivables
Total Short-Term Assets $3.928M $3.321M $6.617M
YoY Change -17.04% -45.75% -48.03%
LONG-TERM ASSETS
Property, Plant & Equipment $10.13K $11.23K $12.42K
YoY Change -27.85% -35.03% -33.86%
Goodwill
YoY Change
Intangibles $16.45M $1.567M $1.655M
YoY Change 844.39% -18.26% -17.46%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.46M $1.578M $1.667M
YoY Change 837.42% -18.41% -17.61%
TOTAL ASSETS
Total Short-Term Assets $3.928M $3.321M $6.617M
Total Long-Term Assets $16.46M $1.578M $1.667M
Total Assets $20.39M $4.899M $8.285M
YoY Change 214.15% -39.18% -43.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.85M $15.84M $11.66M
YoY Change 94.02% 270.03% 122.7%
Accrued Expenses $930.0K $57.98K $556.9K
YoY Change -42.59% -92.75% 364.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.200M $0.00 $0.00
YoY Change -22.08% -100.0%
Total Short-Term Liabilities $23.98M $16.73M $12.59M
YoY Change 43.32% 172.35% 134.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.400M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.080M $1.320M $3.290M
YoY Change 20.78% -56.15% -17.34%
Total Long-Term Liabilities $4.472M $1.324M $3.289M
YoY Change 75.53% -56.09% -17.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.98M $16.73M $12.59M
Total Long-Term Liabilities $4.472M $1.324M $3.289M
Total Liabilities $28.45M $18.06M $15.88M
YoY Change 47.58% 97.16% 69.98%
SHAREHOLDERS EQUITY
Retained Earnings -$201.9M -$173.1M -$163.5M
YoY Change 38.67% 40.78% 40.77%
Common Stock $290.8K $216.9K $208.9K
YoY Change 76.1% 45.1% 39.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.064M -$13.16M -$7.593M
YoY Change
Total Liabilities & Shareholders Equity $20.39M $4.899M $8.285M
YoY Change 214.15% -39.18% -43.86%

Cashflow Statement

Concept 2018 Q4 2018 Q2 2018 Q1
OPERATING ACTIVITIES
Net Income -$14.31M -$9.624M -$17.95M
YoY Change 30.67% 40.91% 121.27%
Depreciation, Depletion And Amortization $150.0K $90.00K $90.00K
YoY Change 66.67% 0.0% 0.0%
Cash From Operating Activities -$17.22M -$6.980M -$10.03M
YoY Change 192.36% -2.51% 13.98%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.25M 3.260M 13.68M
YoY Change 112.34% 183.48% 75.61%
NET CHANGE
Cash From Operating Activities -17.22M -6.980M -10.03M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 13.25M 3.260M 13.68M
Net Change In Cash -3.970M -3.720M 3.650M
YoY Change -1234.29% -38.1% -457.84%
FREE CASH FLOW
Cash From Operating Activities -$17.22M -$6.980M -$10.03M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$17.22M -$6.980M -$10.03M
YoY Change 192.36% -2.51% 14.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2018Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1280000
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
292923481 shares
CY2017Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-8357793
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1296839
CY2017Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-12790510
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-7592679
CY2018Q1 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
300000
CY2018Q1 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
400000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5700000
CY2018Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
626242
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
5073758
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-19797305
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18852414
CY2018Q4 us-gaap Assets
Assets
20390953
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3927875
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
193503678
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
772361
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
500000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
290649949 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
290808960 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
290810
CY2018Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1396974
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4200000
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3075142
CY2018Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1280000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
560013
CY2018Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2826919
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2209254
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1600000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1600000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3075142
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1600000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1600000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1600000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16416962
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16452951
CY2018Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2018Q4 us-gaap Liabilities
Liabilities
28454877
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20390953
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
23001
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23982761
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3075142
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4472116
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
5596974
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
200890
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
92
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10127
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-201858345
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-8063924
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011 shares
CY2018Q4 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
2954624
CY2018Q4 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
347333
CY2018Q4 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
769360
CY2018Q4 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2018Q4 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
565356
CY2018Q4 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
150960607 shares
CY2018Q4 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
155836676 shares
CY2018Q4 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.78
CY2018Q4 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.78
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1775583
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-1103234
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
15841859
CY2018Q2 us-gaap Assets
Assets
4898998
CY2018Q2 us-gaap Assets Current
AssetsCurrent
3320627
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
159764611
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1231445
CY2018Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1100000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216722779 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216881790 shares
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
216881
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
CY2018Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0
CY2018Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1323732
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
757778
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1968846
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1323732
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1531154
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1567143
CY2018Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2018Q2 us-gaap Liabilities
Liabilities
18056969
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4898998
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16733237
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1323732
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1323732
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
0
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
227173
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
92
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11228
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173139396
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13157971
CY2018Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011 shares
CY2018Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1862009
CY2018Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
133600
CY2018Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
3673
CY2018Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2018Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
132385269 shares
CY2018Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.80
CY2018Q2 cydy Treasury Stock Par Value
TreasuryStockParValue
0.001
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
282129
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1172995
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87551801 shares
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-478744
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1574628
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
282129
us-gaap Depreciation And Amortization
DepreciationAndAmortization
178282
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
466934
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6256192
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3178420
us-gaap Investment Income Interest
InvestmentIncomeInterest
1206
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22575959
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Interest Expense
InterestExpense
2462049
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-907606
us-gaap Interest Expense Debt
InterestExpenseDebt
180673
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12411076
us-gaap Operating Expenses
OperatingExpenses
20582050
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12889820
us-gaap Net Income Loss
NetIncomeLoss
-22575959
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4888500
us-gaap Operating Income Loss
OperatingIncomeLoss
-20582050
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1175575
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1647500
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17225348
us-gaap Share Based Compensation
ShareBasedCompensation
529617
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154774327 shares
cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
0
cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
826252
cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
70383
cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
7050651
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19589
dei Amendment Flag
AmendmentFlag
false
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
117534
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155836676 shares
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-459084
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
700000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
19589
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2826919
us-gaap Depreciation And Amortization
DepreciationAndAmortization
243772
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC.
dei Entity Small Business
EntitySmallBusiness
true
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-466412
dei Entity Central Index Key
EntityCentralIndexKey
0001175680
dei Document Period End Date
DocumentPeriodEndDate
2018-11-30
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-466412
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1519603
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.12
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3283113
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4594804
us-gaap Investment Income Interest
InvestmentIncomeInterest
2002
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31545869
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2826919
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Interest Expense
InterestExpense
1904973
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1807629
us-gaap Interest Expense Debt
InterestExpenseDebt
248247
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2262
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25736167
us-gaap Operating Expenses
OperatingExpenses
29176486
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26192989
us-gaap Net Income Loss
NetIncomeLoss
-28718950
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2262
us-gaap Operating Income Loss
OperatingIncomeLoss
-29176486
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2727418
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2018 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total stockholders&#x2019; (deficit) equity, net loss or loss per share.</p> </div>
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24337910
us-gaap Share Based Compensation
ShareBasedCompensation
1510486
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
238731091 shares
dei Trading Symbol
TradingSymbol
CYDY
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
0
cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
23463585
cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
100000
cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
10031717 shares
cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
33483124 shares
cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
0 shares
cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y9M18D
cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y11M19D
cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0
cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.69
cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.75
cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
cydy Percentage Of Outstanding Common Stock To Be Acquired
PercentageOfOutstandingCommonStockToBeAcquired
0.50 pure
cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
225245
cydy Noncash Derivative Liability Associated With Convertible Note Payable
NoncashDerivativeLiabilityAssociatedWithConvertibleNotePayable
1284998
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
cydy Tax Cuts And Jobs Act Of2017 Blended Tax Rate
TaxCutsAndJobsActOf2017BlendedTaxRate
0.2862 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3855468
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
159011 shares
CY2018 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
800000
CY2018 cydy Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
17497051
CY2018 cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
400000
CY2018 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y9M10D
CY2018 cydy Debt Instrument Periodic Addition Payment
DebtInstrumentPeriodicAdditionPayment
0
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1500000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
566609
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-17950100
CY2018Q1 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
14317551
CY2018Q1 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
7566165
CY2018Q1 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2018Q1 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018Q1 cydy Adjustment To Additional Paid In Capital Stock Issued For Board Compensation
AdjustmentToAdditionalPaidInCapitalStockIssuedForBoardCompensation
260190
CY2018Q1 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
1416786
CY2018Q1 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Direct Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToDirectOffering
331621
CY2018Q1 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
166222
CY2018Q1 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Warrant Tender Offer
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToWarrantTenderOffer
2352045
CY2017Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
728843
CY2017Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
274665
CY2017Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
168429
CY2017Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
89136
CY2017Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
829600
CY2017Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.07
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1608743
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
422
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10947685
CY2017Q4 us-gaap Interest Expense
InterestExpense
1002656
CY2017Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
105384
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
10775051
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-10947685
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10775051
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9077172
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
157843773 shares
CY2017Q4 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
3325397
CY2017Q4 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
3725254
CY2017Q4 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2017Q4 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2017Q4 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
312456
CY2017Q4 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Direct Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToDirectOffering
319228
CY2017Q4 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
178664
CY2018Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52954
CY2018Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1227140
CY2018Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
10411
CY2018Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2826919
CY2018Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
154801
CY2018Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
281055
CY2018Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1519603
CY2018Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2663745
CY2018Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1021
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17132299
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2826919
CY2018Q4 us-gaap Interest Expense
InterestExpense
1726585
CY2018Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
143617
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
15687790
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-14305380
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-15687790
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12869244
CY2018Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8342
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259088835 shares
CY2018Q4 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
14964285
CY2018Q4 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-1693354
CY2018Q4 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018Q4 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
25652
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
826252
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254952
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-11628273
CY2017Q3 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
1647500
CY2017Q3 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
1645010
CY2017Q3 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2017Q3 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
283346
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-14413569
CY2018Q3 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
7514300
CY2018Q3 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
985000
CY2018Q3 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-882716
CY2018Q3 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018Q3 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
50544
CY2018Q3 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
75151
CY2018Q3 cydy Debt Instrument Periodic Addition Payment
DebtInstrumentPeriodicAdditionPayment
0
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194551
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-9623623
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104545
CY2018Q2 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
1513631
CY2018Q2 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
2320000
CY2018Q2 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2018Q2 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Direct Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToDirectOffering
206300
CY2018Q2 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
188548
CY2018Q2 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018Q2 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Warrant Tender Offer
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToWarrantTenderOffer
73234
CY2018Q2 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Conversion Of Note Payable
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToConversionOfNotePayable
393686

Files In Submission

Name View Source Status
0001193125-19-005378-index-headers.html Edgar Link pending
0001193125-19-005378-index.html Edgar Link pending
0001193125-19-005378.txt Edgar Link pending
0001193125-19-005378-xbrl.zip Edgar Link pending
cydy-20181130.xml Edgar Link completed
cydy-20181130.xsd Edgar Link pending
cydy-20181130_cal.xml Edgar Link unprocessable
cydy-20181130_def.xml Edgar Link unprocessable
cydy-20181130_lab.xml Edgar Link unprocessable
cydy-20181130_pre.xml Edgar Link unprocessable
d683024d10q.htm Edgar Link pending
d683024dex311.htm Edgar Link pending
d683024dex312.htm Edgar Link pending
d683024dex321.htm Edgar Link pending
d683024dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending